drug development
for rare disease

Odylia Therapeutics 2021 Year End Campaign to Prevent Vision Loss

Our goal is to raise $95,000 by December 31 to support the RPGRIP1 Gene Therapy Program. An anonymous donor will match donations dollar-for-dollar up to $25,000. Your gift will be doubled!


A world reImagined

Odylia is a unique nonprofit biotech bringing life-changing treatments to people with rare genetic disorders, regardless of prevalence or commercial interest. We help groups navigate the complexity of bringing treatments from the lab to patients.

reThinking rare disease…

Odylia is recreating how treatments can be brought to patients with rare disease. By building innovative partnerships and unique solutions, we are changing the paradigm of drug development for rare disease.


Learn how we are making a difference

Learn about the Odylia gene therapy pipeline

Gene Therapy Pipeline

Learn about Odylia's innovative partnerships

Brydge Solutions

Learn about our Odylia team

Our Origin Story

Learn about the impact Odylia is making

Case Studies

reImagine with us…

With little commercial interest in treatments for rare disease, Odylia relies on contributions from individuals, other nonprofit organizations, patient groups, and corporate donors to bring life-changing treatments to patients. Learn more about how you can make a difference.